Alternative Data for Inovio Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 2 | Sign up | Sign up | Sign up |
| Sentiment | 84 | Sign up | Sign up | Sign up |
| Webpage traffic | 10,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 4 | Sign up | Sign up | Sign up |
| Facebook Followers | 4,612 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 107 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 92,379 | Sign up | Sign up | Sign up |
| X Followers | 16,809 | Sign up | Sign up | Sign up |
| X Mentions | 11 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,040 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 27 | Sign up | Sign up | Sign up |
| Linkedin Employees | 222 | Sign up | Sign up | Sign up |
About Inovio Pharmaceuticals
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
| Price | $1.53 |
| Target Price | Sign up |
| Volume | 497,780 |
| Market Cap | $104M |
| Year Range | $1.31 - $2.87 |
| Dividend Yield | 0% |
| Analyst Rating | 50% buy |
| Industry | Biotechnology |
In the news
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOJanuary 27 - GlobeNewswire |
|
INO-3107 At The Crossroads: FDA Review Drives Inovio's Upside And RiskJanuary 21 - SeekingAlpha |
|
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOJanuary 20 - GlobeNewswire |
|
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOJanuary 13 - GlobeNewswire |
|
 |
Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107January 9 - SeekingAlpha |
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOJanuary 6 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 0 | 750,000 | -750,000 | -45M | -45M | -0.870 |
| Q2 '25 | 0 | 740,000 | -740,000 | -24M | -23M | -0.610 |
| Q1 '25 | 65,000 | 0 | 65,000 | -20M | -25.1B | -0.510 |
| Q4 '24 | 120,000 | 780,000 | -660,000 | -19M | -19M | -0.600 |
| Q3 '24 | 0 | 770,000 | -770,000 | -25M | -24M | -0.890 |
Insider Transactions View All
| Zoth Lota S. filed to sell 52,716 shares at $0.6. June 5 '23 |
| Weiner David B. filed to sell 910,124 shares at $1.2. March 13 '23 |
| Weiner David B. filed to sell 904,291 shares at $1.3. February 28 '23 |
| Weiner David B. filed to sell 892,625 shares at $2.7. August 11 '22 |
| BENITO SIMON X filed to sell 75,305 shares at $2.3. July 20 '22 |
Similar companies
Read more about Inovio Pharmaceuticals (INO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Inovio Pharmaceuticals
The Market Cap of Inovio Pharmaceuticals is $104M.
Currently, the price of one share of Inovio Pharmaceuticals stock is $1.53.
The INO stock price chart above provides a comprehensive visual representation of Inovio Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Inovio Pharmaceuticals shares. Our platform offers an up-to-date INO stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Inovio Pharmaceuticals (INO) does not offer dividends to its shareholders. Investors interested in Inovio Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Inovio Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Anavex Life Sciences, and BridgeBio Pharma.
